Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

The treatment effectively promotes hair growth and is well-tolerated.

Using minoxidil on dogs can cause serious cardiovascular damage, including arterial injury and hemorrhagic lesions.

New treatments for PCOS are improving fertility and managing symptoms better.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Early treatment can reverse hair loss from dermal fillers.

New treatments for common hair loss are needed.

New biofabrication technologies could lead to treatments for hair loss.

New cancer treatments aim to reduce side effects and improve effectiveness.